- Home
- About
- Find staff
- Lars Ny
Lars Ny
Professor/ Chief Physician
Department of OncologyDeputy Head of Department
Institute of Clinical Sciences-
Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor-induced CNS
inflammation
Sara Bjursten, Zhiyuan Zhao, Hifaa Al Remawi, Marie Studahl, Ankur Pandita, Joel Simrén, Henrik Zetterberg, Anna-Carin Lundell, Anna Rudin, Lars Ny, Max Levin
EBioMedicine - 2024 -
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit
metastases
Danielle K. Depalo, Michelle M. Dugan, Syeda Mahrukh Hussnain Naqvi, David W. Ollila, Tina J. Hieken, Matthew S. Block, Winan J. van Houdt, Michel W. J. M. Wouters, Sophie J. M. Reijers, Nethanel Asher, Kristy K. Broman, Zoey Duncan, Matilda Anderson, David E. Gyorki, Hayden Snow, Jenny Held, Jeffrey M. Farma, John T. Vetto, Jane Y. C. Hui, Madison Kolbow, Robyn P. M. Saw, Serigne N. Lo, Georgina V. Long, John F. Thompson, Youngchul Kim, Lilit Karapetyan, Lars Ny, Alexander C. J. van Akkooi, Roger Olofsson Bagge, Jonathan S. Zager
CANCER - 2024 -
Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma
metastase
Joakim Karlsson, Vasu R. Sah, Roger Olofsson Bagge, Irina Kuznetsova, Munir Iqba, Samuel Alsén, Sofia Stenqvist, Alka Saxena, Lars Ny, Lisa M Nilsson, Jonas A Nilsson
ELIFE - 2024 -
The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP
trial)
Carl Jacob Holmberg, Lisanne P. Zijlker, Dimitrios Katsarelias, Anne Huibers, Michel W.J.M. Wouters, Yvonne Schrage, Sophie J.M. Reijers, Johannes V. van Thienen, Dirk J. Grünhagen, Anna Martner, Jonas A Nilsson, Alexander C.J. van Akkooi, Lars Ny, Winan J. van Houdt, Roger Olofsson Bagge
European Journal of Surgical Oncology - 2024 -
A phase Ib randomized multicenter trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab for uveal
melanoma
Roger Olofsson Bagge, Axel Nelson, A. Shafazand, Christian Cahlin, A. Carneiro, H. Helgadottir, Max Levin, Magnus Rizell, G. Ullenhag, S. Wiren, Per Lindner, Jonas A Nilsson, Lars Ny
ESMO OPEN - 2024 -
Understanding quality of life issues in patients with advanced melanoma: Phase 1 and 2 in the development of the EORTC advanced melanoma
module
M. D. Egeler, M. van Leeuwen, J. Lai-Kwon, H. Eriksson, I. Bartula, S. Elashwah, L. Fox, M. Van Hemelrijck, M. Jefford, J. Lijnsvelt, Ann-Sophie Lindqvist Bagge, O. Morag, Lars Ny, Roger Olofsson Bagge, A. Rogiers, R. P.M. Saw, S. Serpentini, L. Iannopollo, J. Thompson, H. Tufvesson Stiller, N. Vanlaer, A. C.J. van Akkooi, L. V. van de Poll-Franse
European Journal of Cancer - 2024 -
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint
Immunotherapy
Vasu R. Sah, Henrik Jespersen, J. Karlsson, L. M. Nilsson, M. Bergqvist, I. Johansson, A. Carneiro, H. Helgadottir, Max Levin, G. Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas A Nilsson, Lars Ny
Cancer Research Communications - 2023 -
Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based
study
H. Helgadottir, Lars Ny, G. J. Ullenhag, J. Falkenius, R. Mikiver, Roger Olofsson Bagge, K. Isaksson
Jnci-Journal of the National Cancer Institute - 2023 -
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM
Trial)
Roger Olofsson Bagge, Axel Nelson, A. Shafazand, C. All-Eriksson, Christian Cahlin, N. Elander, H. Helgadottir, J. F. Kiilgaard, S. Kinhult, I. Ljuslinder, J. Mattsson, Magnus Rizell, Malin Sternby Eilard, G. J. Ullenhag, Jonas A Nilsson, Lars Ny, Per Lindnér
Journal of Clinical Oncology - 2023 -
ASO Visual Abstract: Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (>
4 mm)
Carl Jacob Holmberg, Rasmus Mikiver, Karolin Isaksson, Christian Ingvar, Marc Moncrieff, Kari Nielsen, Lars Ny, Johan Lyth, Roger Olofsson Bagge
Annals of surgical oncology - 2023 -
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in
Combination.
Ana Arance, Luis de la Cruz-Merino, Teresa M Petrella, Rahima Jamal, Lars Ny, Ana Carneiro, Alfonso Berrocal, Ivan Márquez-Rodas, Anna Spreafico, Victoria Atkinson, Fernanda Costa Svedman, Andrew Mant, Muhammad A Khattak, Catalin Mihalcioiu, Sekwon Jang, C Lance Cowey, Alan D Smith, Natalyn Hawk, Ke Chen, Scott J Diede, Clemens Krepler, Georgina V Long
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 2023 -
Tumor burden and health-related quality of life in patients with melanoma in-transit
metastases
Hanna Wesslau, Anders Carlander, Lars Ny, Fredrik Wärnberg, Roger Olofsson Bagge, Ann-Sophie Lindqvist Bagge
Cancers - 2023 -
Tumour burden and female sex is negatively associated with health-related quality of life in patients with melanoma in-transit
metastases
Hanna Wesslau, Anders Carlander, Lars Ny, Fredrik Wärnberg, Roger Olofsson Bagge, Ann-Sophie Lindqvist Bagge
European Journal of Surgical Oncology - 2023 -
Targeted Therapy in the Palliative Setting of Colorectal Cancer-Survival and Medical
Costs
Kamuran Inci, Bengt E Nilsson, Lars Ny, U. Stromberg, N. Wilking, Stefan Lindskog, Daniel Giglio
Cancers - 2023 -
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion
Dogs
Elin Forsberg, Rebecca E Riise, S. Saellstrom, Joakim Karlsson, Samuel Alsén, Valentina Bucher, A. E. Hemminki, Roger Olofsson Bagge, Lars Ny, Lisa M Nilsson, H. Ronnberg, Jonas A Nilsson
Cancers - 2023 -
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort
study
Carl Jacob Holmberg, Lars Ny, Tina J. Hieken, Matthew S. Block, Michael J. Carr, Vernon K. Sondak, Christoffer Ortenwall, Dimitrios Katsarelias, Florentia Dimitriou, Alexander M. Menzies, Robyn P. M. Saw, Aljosja Rogiers, Richard J. Straker, Giorgos Karakousis, Rona Applewaite, Lalit Pallan, Dale Han, John T. Vetto, David E. Gyorki, Emilia Nan Tie, Maria Grazia Vitale, Paulo A. Ascierto, Reinhard Dummer, Jade Cohen, Jane Y. C. Hui, Jacob Schachter, Nethanel Asher, H. Helgadottir, Harvey Chai, Hidde Kroon, Brendon Coventry, Luke D. Rothermel, James Sun, Matteo S. Carlino, Zoey Duncan, Kristy Broman, Jeffrey Weber, Ann Y. Lee, Russell S. Berman, Juri Teras, David W. Ollila, Georgina Long, Jonathan S. Zager, Alexander van Akkooi, Roger Olofsson Bagge
EUROPEAN JOURNAL OF CANCER - 2022 -
Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant
melanoma
Vasu R. Sah, Joakim Karlsson, Henrik Jespersen, Mattias F Lindberg, Lisa M Nilsson, Lars Ny, Jonas A Nilsson
Melanoma Research - 2022 -
Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor
efficacy.
Fernanda Costa Svedman, Marie Jalsenius, Vitali Grozman, Mattias Bergqvist, Fabian Söderdahl, Samuel Rotstein, Lars Ny, Suzanne Egyhazi Brage, Hildur Helgadottir
Acta oncologica (Stockholm, Sweden) - 2022 -
Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is
unnecessary
I. Johansson, D. Tempel, J. T. Dwarkasing, B. Rentroia-Pacheco, J. Mattsson, Lars Ny, Roger Olofsson Bagge
EJSO - 2022 -
Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I-II Melanoma Patients at Risk of Disease
Relapse.
Evalyn E A P Mulder, Iva Johansson, Dirk J Grünhagen, Dennie Tempel, Barbara Rentroia-Pacheco, Jvalini T Dwarkasing, Daniëlle Verver, Antien L Mooyaart, Astrid A M van der Veldt, Marlies Wakkee, Tamar E C Nijsten, Cornelis Verhoef, Jan Mattsson, Lars Ny, Loes M Hollestein, Roger Olofsson Bagge
Cancers - 2022 -
Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter
trial.
Ellen Backlund, Muyi Yang, Vitali Grozman, Giuseppe Masucci, Johan Falkenius, Hanna Eriksson, Braslav Jovanovic, Katarina Hammarlund, Ulf Isacsson, Calin Radu, Edvard Abel, Kristin Karlsson, Ricardo Palanco Zamora, Peter Wersäll, Ulrika Edbäck, Stina Wickström, Eva Darai Ramqvist, Suzanne Egyhazi Brage, Rolf Kiessling, Kristina Viktorsson, Bo Franzén, Rolf Lewensohn, Roger Olofsson Bagge, Gustav J Ullenhag, Lars Ny, Karin Lindberg, Hildur Helgadottir
Acta oncologica (Stockholm, Sweden) - 2022 -
Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint
Inhibitors
F. C. Svedman, M. Jalsenius, V. Höiom, V. Grozman, M. Bergqvist, F. Söderdahl, H. Eriksson, S. Rotstein, Lars Ny, P. A. Ascierto, S. E. Brage, H. Helgadottir
Cancers - 2022 -
PD-1 inhibitor therapy of basal cell carcinoma with pulmonary
metastasis.
I Johansson, Max Levin, Levent Akyürek, Roger Olofsson Bagge, Lars Ny
Journal of the European Academy of Dermatology and Venereology - 2022 -
Using patient-derived xenografts as sources of 3D tumor sphere cultures to study autologous tumor-infiltrating lymphocytes in metastatic uveal
melanoma
Vasu R. Sah, J. Karlsson, Valentina Bucher, Roger Olofsson Bagge, Lars Ny, L. Nilsson, J. Nilsson
European Journal of Cancer - 2022 -
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal
melanoma
Lars Ny, Henrik Jespersen, Joakim Karlsson, Samuel Alsén, Stefan Filges, C. All-Eriksson, B. Andersson, A. Carneiro, H. Helgadottir, Max Levin, I. Ljuslinder, Roger Olofsson Bagge, Vasu R. Sah, Ulrika Stierner, Anders Ståhlberg, G. Ullenhag, Lisa M Nilsson, Jonas A Nilsson
Nature Communications - 2021 -
The efficacy of immunotherapy for in-transit metastases of melanoma: an analysis of randomized controlled
trials
Roger Olofsson Bagge, Lars Ny, P. A. Ascierto, F. S. Hodi, J. Larkin, C. Robert, J. Schachter, J. S. Weber, G. V. Long, A. C. J. van Akkooi
Melanoma research - 2021 -
Intussusceptive angiogenesis in human metastatic malignant
melanoma.
Ankur Pandita, Matias Ekstrand, Sara Bjursten, Zhiyuan Zhao, Per Fogelstrand, Kristell Le Gal, Lars Ny, Martin O Bergo, Joakim Karlsson, Jonas A Nilsson, Levent Akyürek, Malin Levin, Jan Borén, Andrew J Ewald, Keith E Mostov, Max Levin
The American Journal of Pathology - 2021 -
Clinical outcomes in cancer patients with COVID-19 in
Sweden.
Lisa Bondeson, Anna Thulin, Lars Ny, Max Levin, Johanna Svensson, Magnus Lindh, Zhiyuan Zhao
Acta oncologica (Stockholm, Sweden) - 2021 -
Early rise in brain damage markers and high ICOS expression in CD4+and CD8+T cells during checkpoint inhibitor-induced
encephalomyelitis
Sara Bjursten, Ankur Pandita, Zhiyuan Zhao, C. Frojd, Lars Ny, C. Jensen, T. Ullerstam, Henrik Jespersen, Jan Borén, Malin Levin, Henrik Zetterberg, Anna Rudin, Max Levin
Journal for Immunotherapy of Cancer - 2021 -
Surgery of metastatic melanoma after systemic therapy - the SUMMIST trial: study protocol for a randomized controlled
trial.
Carl Jacob Holmberg, Dimitrios Katsarelias, Henrik Jespersen, Ana Carneiro, Nils O Elander, Hildur Helgadottir, Karolin Isaksson, Malin Jansson, Sara Wirén, Gustav J Ullenhag, Lars Ny, Roger Olofsson Bagge
Acta oncologica (Stockholm, Sweden) - 2021 -
Checkpoint Inhibition Causing Complete Remission of Metastatic Combined Hepatocellular-Cholangiocarcinoma after Hepatic
Resection
Magnus Rizell, Fredrik Åberg, Mats Perman, Lars Ny, Liselotte Sten, Farida Hashimi, Joar Svanvik, Per Lindnér
Case Reports in Oncology - 2020 -
Radiation of the urinary bladder attenuates the development of lipopolysaccharide-induced
cystitis
Lucie Podmolíková, Marie Francoise Mukanyangezi, Annika Janina Dahlqvist, Åsa Torinsson Naluai, Lars Ny, Daniel Giglio
International Immunopharmacology - 2020 -
The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma-A Nation-Wide Swedish Population-Based Retrospective Register
Study.
Dimitrios Katsarelias, Hanna Eriksson, Rasmus Mikiver, Isabelle Krakowski, Jonas A Nilsson, Lars Ny, Roger Olofsson
Cancers - 2020 -
Molecular profiling of driver events in metastatic uveal
melanoma
Joakim Karlsson, Lisa M Nilsson, Suman Mitra, Samuel Alsén, Ganesh V Shelke, Vasu R. Sah, Elin Forsberg, Ulrika Stierner, C. All-Eriksson, Berglind Osk Einarsdottir, Henrik Jespersen, Lars Ny, Per Lindnér, Erik Larsson, Roger Olofsson Bagge, Jonas A Nilsson
Nature Communications - 2020 -
BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and
meta-analysis.
Lars Ny, M Hernberg, M Nyakas, J Koivunen, L Oddershede, M Yoon, X Wang, P Guyot, J Geisler
Acta oncologica (Stockholm, Sweden) - 2020 -
Immune Checkpoint Inhibitor-Induced Polymyositis and Myasthenia Gravis with Fatal
Outcome.
Daniel Giglio, Henrik Berntsson, Åsa Fred, Lars Ny
Case reports in oncology - 2020 -
Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse
models
Lars Ny, Larissa Rizzo, Valerio Belgrano, Jón Karlsson, Henrik Jespersen, Louise Carstam, Roger Olofsson Bagge, Lisa M Nilsson, Jonas A Nilsson
Annals of Oncology - 2020 -
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced
Melanoma.
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Anna Maria Di Giacomo, Laurent Mortier, Piotr Rutkowski, Jessica C Hassel, Catriona M McNeil, Ewa Anna Kalinka, Céleste Lebbé, Julie Charles, Micaela M Hernberg, Kerry J Savage, Vanna Chiarion-Sileni, Catalin Mihalcioiu, Cornelia Mauch, Ana Arance, Francesco Cognetti, Lars Ny, Henrik Schmidt, Dirk Schadendorf, Helen Gogas, Jesús Zoco, Sandra Re, Paolo A Ascierto, Victoria Atkinson
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 2020 -
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout
Mice
Elin Forsberg, Mattias F Lindberg, Henrik Jespersen, Samuel Alsén, Roger Olofsson Bagge, M. Donia, I. M. Svane, Ola Nilsson, Lars Ny, Lisa M Nilsson, Jonas A Nilsson
Cancer Research - 2019 -
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label
study.
Henrik Jespersen, Roger Olofsson Bagge, Gustav Ullenhag, Ana Carneiro, Hildur Helgadottir, Ingrid Ljuslinder, Max Levin, Charlotta All-Eriksson, Bengt Andersson, Ulrika Stierner, Lisa M Nilsson, Jonas A Nilsson, Lars Ny
BMC cancer - 2019 -
Surgery for gastrointestinal metastases of malignant melanoma - a retrospective exploratory
study
Carl Jacob Holmberg, Gulan Alwan, Lars Ny, Roger Olofsson Bagge, Dimitrios Katsarelias
World Journal of Surgical Oncology - 2019 -
Real-world data on PD-1 inhibitor therapy in metastatic
melanoma
A. Arheden, J. Skalenius, Sara Bjursten, Ulrika Stierner, Lars Ny, Max Levin, Henrik Jespersen
Acta Oncologica - 2019 -
A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in
Sweden.
Karolin Isaksson, Dimitrios Katsarelias, Rasmus Mikiver, Ana Carneiro, Lars Ny, Roger Olofsson Bagge
Annals of surgical oncology - 2019 -
Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3
Trial.
Paolo A Ascierto, Georgina V Long, Caroline Robert, Benjamin Brady, Caroline Dutriaux, Anna Maria Di Giacomo, Laurent Mortier, Jessica C Hassel, Piotr Rutkowski, Catriona McNeil, Ewa Kalinka-Warzocha, Kerry J Savage, Micaela M Hernberg, Celeste Lebbé, Julie Charles, Catalin Mihalcioiu, Vanna Chiarion-Sileni, Cornelia Mauch, Francesco Cognetti, Lars Ny, Ana Arance, Inge Marie Svane, Dirk Schadendorf, Helen Gogas, Abdel Saci, Joel Jiang, Jasmine Rizzo, Victoria Atkinson
JAMA oncology - 2019 -
Ökad hälsomedvetenhet kan öka människors
hälsoångest?
Ann-Sophie Lindqvist Bagge, Mats Lekander, Lars Ny, Roger Olofsson Bagge, Claudia Fahlke
Läkartidningen - 2019 -
Förmedla hälsopsykologisk kunskap utan att öka hälsorelaterad
oro
Ann-Sophie Lindqvist Bagge, Mats Lekander, Lars Ny, Roger Olofsson Bagge, Claudia Fahlke
Psykologtidningen - 2019 -
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic
melanoma
Berglind Osk Einarsdottir, Joakim Karlsson, Elin Söderberg, Mattias F Lindberg, Elisa Funck-Brentano, Henrik Jespersen, Siggeir Fannar Brynjólfsson, Roger Olofsson Bagge, Louise Carstam, M. Scobie, T. Koolmeister, O. Wallner, Ulrika Stierner, U. W. Berglund, Lars Ny, Lisa M Nilsson, Erik Larsson, T. Helleday, Jonas A Nilsson
Cell Death & Disease - 2018 -
Mouse avatars take off as cancer
models.
Jonas A Nilsson, Roger Olofsson Bagge, Lars Ny
Nature - 2018 -
Checkpoint inhibitor-induced sarcoid reaction mimicking bone
metastases.
Henrik Jespersen, Sara Bjursten, Lars Ny, Max Levin
The Lancet Oncology - 2018 -
BET bromodomain inhibitors synergize with ATR inhibitors in melanoma in
melanoma.
Somsundar Veppil Muralidharan, Berglind Osk Einarsdottir, Joydeep Bhadury, Mattias F Lindberg, Jin Wu, Eric Campeau, Roger Olofsson Bagge, Ulrika Stierner, Lars Ny, Lisa M Nilsson, Jonas A Nilsson
Cell Death & Disease - 2017 -
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse
model.
Henrik Jespersen, Mattias F Lindberg, Marco Donia, Elin Söderberg, Rikke Andersen, Ulrich Keller, Lars Ny, Inge Marie Svane, Lisa M Nilsson, Jonas A Nilsson
Nature communications - 2017 -
Hyperbaric oxygen treatment reverses radiation induced pro-fibrotic and oxidative stress responses in a rat
model
Nicklas Oscarsson, Lars Ny, Johan Mölne, F. Lind, Sven-Erik Ricksten, Heléne Seeman-Lodding, Daniel Giglio
Free Radical Biology and Medicine - 2017 -
Great advances in the systemic treatment in malignant melanoma
patients
Gustav Ullenhag, Johan Hansson, Lars Ny
Lakartidningen - 2017 -
Adjuvant therapies for malignant
melanoma
Roger Olofsson Bagge, Lars Ny
British Journal of Surgery - 2016 -
Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived
xenografts.
Joydeep Bhadury, Berglind Osk Einarsdottir, Agnieszka Podraza, Roger Olofsson Bagge, Ulrika Stierner, Lars Ny, Marcela Davila Lopez, Jonas A Nilsson
Oncotarget - 2016 -
Downregulation of toll-like receptor 4 and IL-6 following irradiation of the rat urinary
bladder
Daniel Giglio, Caroline Wasén, Johan Mölne, Dariusz Suchy, John Swanpalmer, J. Jabonero Valbuena, Gunnar Tobin, Lars Ny
Clinical and Experimental Pharmacology and Physiology - 2016 -
Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic
Perfusion.
Ilan Ben-Shabat, Valerio Belgrano, Lars Ny, Jonas A Nilsson, Per Lindnér, Roger Olofsson Bagge
Annals of surgical oncology - 2016 -
Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled
trial.
Roger Olofsson Bagge, Lars Ny, Charlotta All-Ericsson, Malin Sternby Eilard, Magnus Rizell, Christian Cahlin, Ulrika Stierner, Ulf Lönn, Johan Hansson, Ingrid Ljuslinder, Lotta Lundgren, Gustav Ullenhag, Jens Folke Kiilgaard, Jonas A Nilsson, Per Lindnér
Trials - 2015 -
Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment
decisions.
Berglind Osk Einarsdottir, Roger Olofsson Bagge, Joydeep Bhadury, Henrik Jespersen, Jan Mattsson, Lisa M Nilsson, Katarina Truvé, Marcela Davila Lopez, Peter Naredi, Ola Nilsson, Ulrika Stierner, Lars Ny, Jonas A Nilsson
Oncotarget - 2014 -
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled
trial.
Roger Olofsson, Lars Ny, Malin Sternby Eilard, Magnus Rizell, Christian Cahlin, Ulrika Stierner, Ulf Lönn, Johan Hansson, Ingrid Ljuslinder, Lotta Lundgren, Gustav Ullenhag, Jens Folke Kiilgaard, Jonas A Nilsson, Per Lindnér
Trials - 2014 -
Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor
types.
Nils J Fredriksson, Lars Ny, Jonas A Nilsson, Erik Larsson
Nature genetics - 2014 -
Bacterial flora of the human oral cavity, and the upper and lower
esophagus.
E. Norder Grusell, Gunnar Dahlén, Magnus Ruth, Lars Ny, Marianne Quiding-Järbrink, Henrik Bergquist, Mogens Bove
Diseases of the esophagus - 2013 -
Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental
pain.
Anne L. Krarup, Lars Ny, Jenny Gunnarsson, Frederik Hvid-Jensen, Sofia Zetterstrand, Magnus Simrén, Peter Funch-Jensen, Mark Berner Hansen, Asbjørn Mohr Drewes
Scandinavian journal of gastroenterology - 2013 -
Nitric oxide and endothelin-1 release after one-lung ventilation during thoracoabdominal
esophagectomy.
M Lund, Lars Ny, R E Malmström, J O Lundberg, A Ost, M Björnstedt, L Lundell, J A Tsai
Diseases of the esophagus - 2013 -
The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy
volunteers.
W O Rohof, A Lei, D P Hirsch, Lars Ny, M Astrand, M B Hansen, G E Boeckxstaens
Alimentary pharmacology & therapeutics - 2012 -
Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal
pain.
Anne L. Krarup, Lars Ny, M Astrand, Antal Bajor, F Hvid-Jensen, M B Hansen, Magnus Simrén, P Funch-Jensen, A M Drewes
Alimentary pharmacology & therapeutics - 2011 -
Risk of clinically relevant bleeding in warfarin-treated patients--influence of SSRI
treatment.
Susanna Maria Wallerstedt, Hanna Gleerup, Anders Sundström, Lennart Stigendal, Lars Ny
Pharmacoepidemiology and drug safety - 2009 -
A magnetic resonance imaging study of intestinal dilation in Trypanosoma cruzi-infected mice deficient in nitric oxide
synthase.
Lars Ny, Hua Li, Shankar Mukherjee, Katarina Persson, Bo Holmqvist, Dazhi Zhao, Vitaliy Shtutin, Huan Huang, Louis M Weiss, Fabiana S Machado, Stephen M Factor, John Chan, Herbert B Tanowitz, Linda A Jelicks
The American journal of tropical medicine and hygiene - 2008 -
Reporting of adverse drug reactions may be influenced by feedback to the reporting
doctor
Susanna Maria Wallerstedt, Gertrud Brunlöf, Mari Louise Johansson, Carina Tukukino, Lars Ny
Eur J Clin Pharmacol - 2007 -
Acid challenge to the esophageal mucosa: effects on local nitric oxide formation and its relation to epithelial
functions
Mogens Bove, M. Vieth, Anna Casselbrant, Lars Ny, L. Lundell, Magnus Ruth
Dig Dis Sci - 2005 -
Acid challenge to the human esophageal mucosa: effects on epithelial architecture in health and
disease
Mogens Bove, M. Vieth, F. Dombrowski, Lars Ny, Magnus Ruth, L. Lundell
Dig Dis Sci - 2005 -
Epithelial barrier integrity and intraluminal nitric oxide production in response to acid perfusion of the ferret
oesophagus
Mogens Bove, Magnus Ruth, L. Lundell, Lars Ny
Acta Physiol Scand - 2005 -
Nitric oxide production in the sphenoidal sinus by the inducible and constitutive isozymes of nitric oxide
synthase
Karin Petruson, Joacim Stalfors, Karl-Erik Jacobsson, Lars Ny, Björn Petruson
Rhinology - 2005 -
Effects of Dietary Nitrate on Oesophageal Motor Function and Gastro-Oesophageal Acid Exposure in Healthy Volunteers and Reflux
Patients
Mogens Bove, Lars Lundell, Lars Ny, Anna Casselbrant, Lars Fändriks, A Pettersson, Magnus Ruth
Digestion - 2003